Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Clarity Pharmaceuticals Ltd

Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.

Clarity Pharmaceuticals Ltd CU6 ASX

A radiopharmaceutical company developing targeted cancer therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New PET scan agent spots prostate cancer missed by standard tests

Diagnosis Completed

This phase 2 study tested a new radioactive imaging agent called 64Cu-SAR-BBN in 53 men with prostate cancer that had returned after treatment but was not visible on standard PSMA PET scans. The goal was to see if this agent could safely and accurately detect where the cancer had…

Phase: PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis

Last updated Jun 27, 2026 07:57 UTC